scorecardresearch
Add as a preferred source on Google
Tuesday, December 23, 2025
TopicMedicines

Topic: Medicines

India’s largest wholesale medicine market closed until 4 June due to sudden Covid outbreak

Mohana Basu -
At least 12 people from Bhagirath Palace in Delhi's Chandni Chowk have tested positive for Covid after India entered the fourth phase of lockdown on 18 May.

Indian firms Ipca, Zydus Cadila get big US orders for chloroquine to fight COVID-19

Himani Chandna -
Anti-malaria drug is one of those being tested as a cure for coronavirus, and US FDA has placed the order after President Trump’s endorsement of it.

These 5 anti-viral drugs and therapies could help treat COVID-19

Himani Chandna -
Researchers and pharmaceutical giants across the world are scrambling to find a cure for coronavirus which has been declared a pandemic.

What are APIs and how they threaten India’s status of a ‘pharmacy to the world’

Himani Chandna -
Despite being a leading supplier of medicines to several countries, India is highly dependent on China for raw materials even to produce medicines as basic as Crocin.

Year after HC order, Modi govt to act against e-pharmacies selling drugs without licences

Himani Chandna -
Quoting Delhi HC's December 2018 orders, India’s drug regulator has written to all states & UTs to take necessary action with respect to online sale of medicines.

Big Pharma has failed. It’s been 35 years since a new class of antibiotics entered the market

Claas Kirchhelle -
Antibiotics are among the most important medicines known to humankind, but we are running out of it.

Indians pay 70% less than the global median to buy medicines, study finds

Himani Chandna -
A study compared the prices of drug compounds across the world and found that only Thailand, Kenya, Malaysia and Indonesia are cheaper than India.

Danish firm gets FDA approval for oral diabetes pill, no word yet on India launch

Himani Chandna -
India has 7.2 crore people with diabetes and oral pills will help them avoid the pain of puncturing themselves again and again.

India again lobbies with Beijing to sell its generic medicines amid US-China trade war

Himani Chandna -
Modi govt has asked China to provide quick clearances for made-in-India drugs at the India-China Strategic Economic Dialogue meet held between 7-9 September.

Why sale of Naloxone, a life-saving drug that reverses opioid overdose, is falling in India

Himani Chandna -
Use of Naloxone in India has dropped by nearly half since 2014 — from 30,000 units to 15,700 units in 2018-2019.
1...3456Page 4 of 6

On Camera

YourTurn

Opinion

Bondi Beach, Bangladesh lynching — once again, the elephant in the room will be side-stepped

Meenakashi Lekhi -
Perhaps there is need for a moral ‘jihad’ against those indulging in the promulgation of terror in the name of religion.

Bengaluru & Hyderabad share many of Dubai’s characteristics. Why they don’t function the same

India’s PDS isn’t future-ready. It needs five major reforms

Economy

China is taking India to WTO over subsidies, again. Here’s what it’s arguing before trade body

Keshav Padmanabhan -
Dispute will now move to consultative process, which allows the two sides to come to an amicable agreement within 60 days.

Defence

Turkiye delivers second MILGEM-class corvette Khaibar to Pakistan Navy, two others in making

Vaibhav Pant -
Contract for construction of four MILGEM-class ships was signed in 2018. PNS Bedir is to be delivered by June 2026, while PNS Tariq is due for delivery in first quarter of 2027.

National Interest

Dhurandhar shows hard cinema is soft power and Pakistan is unapologetically the target

Shekhar Gupta -
If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.